BUCCOLAM 2.5 mg oromucosal solution clinical trials

An Open-Label, Fixed-Sequence, Drug-Drug Interaction Study in Healthy Participants to Evaluate the Effect of AGMB-129 on the Pharmacokinetics of Midazolam, a Sensitive Index Substrate of CYP3A4

This study is looking at how a new medicine, AGMB-129, interacts with another common medicine called midazolam in healthy volunteers. The goal is to understand how their bodies process these medicines when taken together.